产品详情
简单介绍：
Anti-Phospho-Caspase-9 (Thr125)抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-Phospho-Caspase-9 (Thr125)抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-Phospho-Caspase-9 (Thr125)
Cat. Number:
Anti-Phospho-Caspase-9 (Thr125)抗体KL-3082R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein can undergo autoproteolytic
Anti-Phospho-Caspase-9 (Thr125)抗体processing and activation by the apoptosome, a protein complex of cytochrome c and the apoptotic peptidase activating factor 1; this step is thought to be one of the earliest in the caspase activation cascade. This protein is thought to play a central role in apoptosis and to be a tumor suppressor. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]
Also known as:
APAF 3; APAF3; Apoptosis
Anti-Phospho-Caspase-9 (Thr125)抗体related cysteine peptidase; Apoptotic protease activating factor 3; Apoptotic protease Mch 6; CASP 9; CASP9; Caspase 9 Dominant Negative; Caspase 9 precursor; Caspase 9c; Caspase9; EC 3.4.22.; ICE LAP6; ICE like apoptotic protease 6; MCH6 antibody RNCASP9; CASP9_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
Anti-Phospho-Caspase-9 (Thr125)抗体
●
Immunogen: KLH conjugated Synthesised phosphopeptide derived from human Caspase-9 around the phosphorylation site of Thr125.
●
Predicted Molecular Weight: 35kDa.
Storage:
Shipped at 4℃, Store at -20℃
Anti-Phospho-Caspase-9 (Thr125)抗体(Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000
Anti-Phospho-Caspase-9 (Thr125)抗体IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl141Mu02 尿激酶型纤溶酶原激活因子受体(ukl)多克隆抗体 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl142Mu02 细胞间粘附分子5(ICAM5)多克隆抗体 Polyclonal Antibody to Intercellular Adhesion Molecule 5 (ICAM5)
kl144Mu02 血管内皮生长因子B(VEGFB)多克隆抗体 Polyclonal Antibody to Vascular Endothelial Growth Factor B (VEGFB)
kl145Mu02 血管内皮生长因子C(VEGFC)多克隆抗体 Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
kl146Mu02 血管内皮生长因子D(VEGFD)多克隆抗体 Polyclonal Antibody to Vascular Endothelial Growth Factor D (VEGFD)
kl147Mu02 脂联素受体1(ADIPOR1)多克隆抗体 Polyclonal Antibody to Adiponectin Receptor 1 (ADIPOR1)
kl149Mu02 Ⅳ型胶原α1(COL4α1)多克隆抗体 Polyclonal Antibody to Collagen Type IV Alpha 1 (COL4a1)
kl151Mu02 激肽释放酶3(KLK3)多克隆抗体 Polyclonal Antibody to Kallikrein 3 (KLK3)
kl153Mu02 甲胎蛋白(αFP)多克隆抗体 Polyclonal Antibody to Alpha-Fetoprotein (aFP)
kl154Mu02 糖抗原125(CA125)多克隆抗体 Polyclonal Antibody to Carbohydrate Antigen 125 (CA125)
kl159Hu02 鳞状细胞癌抗原2(SCCA2)多克隆抗体 Polyclonal Antibody to Squamous Cell Carcinoma Antigen 2 (SCCA2)
kl159Mu02 鳞状细胞癌抗原2(SCCA2)多克隆抗体 Polyclonal Antibody to Squamous Cell Carcinoma Antigen 2 (SCCA2)
